Analyst Downgrades – Pharmerica Corporation (NYSE:PMC) Stock Gets Downgraded By Barrington Research from Outperform to Underperform

0

Analyst Ratings For Pharmerica Corporation (NYSE:PMC)

Today, Pharmerica Corporation (NYSE:PMC) stock was downgraded by Barrington Research from Outperform to Underperform.

There are 1 sell rating, 1 buy rating on the stock.

The current consensus rating on Pharmerica Corporation (NYSE:PMC) is Hold (Score: 2.00) with a consensus target price of per share, a potential .

Some recent analyst ratings include

  • 8/3/2017-Barrington Research was Downgraded by analysts at Barrington Research from a “Outperform ” rating to a ” Underperform” rating.
  • 8/2/2017-KeyCorp was Downgraded by analysts at KeyCorp from a “Overweight” rating to a “” rating.
  • 6/7/2016-Bank of America Corporation initiated coverage with a Buy rating.
  • 3/15/2016-Credit Suisse Group initiated coverage with a Outperform rating.
  • 12/30/2015-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Pharmerica Corporation (NYSE:PMC)
Pharmerica Corporation (NYSE:PMC) has insider ownership of 5.04% and institutional ownership of 92.75%.

  • On 12/2/2015 Robert A Mckay, SVP, sold 2,993 with an average share price of $34.42 per share and the total transaction amounting to $103,019.06. View SEC Filing
  • On 11/11/2015 Mark Lindemoen, SVP, sold 3,790 with an average share price of $34.71 per share and the total transaction amounting to $131,550.90. View SEC Filing
  • On 6/16/2015 Robert A Mckay, SVP, sold 7,000 with an average share price of $32.75 per share and the total transaction amounting to $229,250.00. View SEC Filing
  • On 6/3/2015 Gregory S Weishar, CEO, sold 104,150 with an average share price of $32.63 per share and the total transaction amounting to $3,398,414.50. View SEC Filing
  • On 6/1/2015 Mark Lindemoen, SVP, sold 4,500 with an average share price of $33.27 per share and the total transaction amounting to $149,715.00. View SEC Filing
  • On 3/12/2015 Berard Tomassetti, CAO, sold 3,344 with an average share price of $26.44 per share and the total transaction amounting to $88,415.36. View SEC Filing
  • On 3/12/2015 Thomas A Caneris, SVP, sold 7,495 with an average share price of $26.52 per share and the total transaction amounting to $198,767.40. View SEC Filing

Recent Trading Activity for Pharmerica Corporation (NYSE:PMC)
Shares of Pharmerica Corporation closed the previous trading session at 28.95 up +3.90 15.57% with 8,063,935 shares trading hands.